Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5611 AL 5625

Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes

Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2010 Apr;18(4):332-40. doi: 10.1097/JGP.0b013e3181cc0333.

The accuracy of short clinical rating scales in neuropathologically diagnosed dementia

Gustafson L, Englund E, Brunnström H, Brun A, Erikson C, Warkentin S, Passant U.

Am J Geriatr Psychiatry. 2010 Sep;18(9):810-20. doi: 10.1097/JGP.0b013e3181cdef7a.

Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort

Sparks DL, Kryscio RJ, Connor DJ, Sabbagh MN, Sparks LM, Lin Y, Liebsack C.

Neurodegener Dis. 2010;7(1-3):183-6. doi: 10.1159/000295660. Epub 2010 Mar 12.

Intravenous immunoglobulins as a treatment for Alzheimer's disease: rationale and current evidence

Dodel R, Neff F, Noelker C, Pul R, Du Y, Bacher M, Oertel W.

Drugs. 2010 Mar 26;70(5):513-28. doi: 10.2165/11533070-000000000-00000.

Apple juice improved behavioral but not cognitive symptoms in moderate-to-late stage Alzheimer's disease in an open-label pilot study

Remington R, Chan A, Lepore A, Kotlya E, Shea TB.

Am J Alzheimers Dis Other Demen. 2010 Jun;25(4):367-71. doi: 10.1177/1533317510363470. Epub 2010 Mar 25.

REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease

Robert PH, Mulin E, Malléa P, David R.

CNS Neurosci Ther. 2010 Oct;16(5):263-71. doi: 10.1111/j.1755-5949.2009.00132.x.

Long-lasting hemianopia due to PCA

Delaj L, D'Alessandro R, Stracciari A, Fonti C, Cretella L, Lodi R.

J Neurol. 2010 Sep;257(9):1562-4. doi: 10.1007/s00415-010-5540-5. Epub 2010 Mar 30.

Progression of atrophy in Alzheimer's disease and related disorders

Whitwell JL.

Neurotox Res. 2010 Nov;18(3-4):339-46. doi: 10.1007/s12640-010-9175-1. Epub 2010 Mar 30.

Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes

Mosconi L, Berti V, Swerdlow RH, Pupi A, Duara R, de Leon M.

Hum Genomics. 2010 Feb;4(3):170-93. doi: 10.1186/1479-7364-4-3-170.

French-English cross-linguistic comparison and diagnostic impact of the AD-8 dementia screening questionnaire in a geriatric assessment clinic

Koski L, Xie H, Konsztowicz S, Tetteh R.

Dement Geriatr Cogn Disord. 2010;29(3):265-74. doi: 10.1159/000289815. Epub 2010 Apr 6.

[Premature immunosenescence: a pathogenetic factor in Alzheimer's disease?]

Richartz-Salzburger E, Stransky E, Laske C, Köhler N.

Nervenarzt. 2010 Jul;81(7):837-43. doi: 10.1007/s00115-009-2918-7.

100th anniversary of Perusini's second case: patient RM and his kindred

Braun B, Stadlober-Degwerth M, Hajak G, Klünemann HH.

Am J Alzheimers Dis Other Demen. 2010 May;25(3):189-92. doi: 10.1177/1533317509356689. Epub 2010 Apr 14.

Cognition and function in Alzheimer's disease: identifying the transitions from moderate to severe disease

Schwam E, Xu Y.

Dement Geriatr Cogn Disord. 2010;29(4):309-16. doi: 10.1159/000269837. Epub 2010 Apr 16.

Physical activity and implications on well-being in mild Alzheimer's disease: A qualitative case study on two men with dementia and their spouses

Cedervall Y, Aberg AC.

Physiother Theory Pract. 2010 May;26(4):226-39. doi: 10.3109/09593980903423012.

Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease

Dong J, Revilla-Sanchez R, Moss S, Haydon PG.

Neuropharmacology. 2010 Sep-Oct;59(4-5):268-75. doi: 10.1016/j.neuropharm.2010.04.007. Epub 2010 Apr 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias